Biotech Values

[iwfal]

So one ought to consider the weighted probabilities of these two kinds of events.

Ok, let me make my original comment totally unambiguous:

Personally I couldn't care less whether I croak from an in-stent thrombosis or restenosis. I only care about the odds of death.

My point was that the mortality rates for DES vs BMS are about the same. (If anything the DES has a lower mortality rate.) What do I care if the mortality from DES is all late thrombosis while the mortality from BMS is intractable restenosis (or xxxxx)?

Further commentary is that given the fact that the mortality rates are about the same with the edge to DES:

a) it should be no surprise that the BMS has late stage thrombosis as well. If BMS didn't have late thrombosis then it has something else.

b) all this talk about the horrors of DES (vs BMS) is bizzarre. It all reads as if we should go back to BMS and, given the mortality data, there is very little data to back this up. Somehow giving a name to the cause of death has made the evil look bigger than it is. (Undoubtedly a human nature problem.)